【文獻標題】Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits
【作者】Xiaowei Zhang, MD, PhD;Zhiwei Zhang, BS;Yungang Zhao, PhD;et.al
【作者單位】天津醫科大學(Tianjin Medical University)
【文獻中引用產品】
兔胰高血糖素樣肽1(GLP-1)ELISA試劑盒
兔8羥基脫氧鳥苷(8-OHdG)ELISA試劑盒
【關鍵詞】atrial fibrillation ,dipeptidyl peptidase-4 inhibitors ,mitochondrial biogenesis , mitochondrial function
【DOI】doi.org/10.1161/JAHA.117.005945
【影響因子(IF)】7.0
【出版期刊】《American Heart Association》
【產品原文引用】
Serum Biochemical, Inflammatory, and Oxidative Stress Measurements
Serum biochemical examination including fasting glucose at the 8th week, total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol,and creatinine level were detected using a full automatic biochemical analyzer. Fasting insulin and GLP-1 level were assessed using a rabbit insulin ELISA kKit (Wuhan Huamei Biological Engineering Co, Ltd) and rabbit GLP-1 ELISA kit (Shanghai Huding Biological Technology Co) according to the manufacturers’ instructions, respectively. A lipid peroxidation malondialdehyde (MDA) assay kit (Nanjing Jianchen Bioengineering Institute) was used to detect the serum MDA level,and another oxidative stress–related marker serum 8-hydroxy-20-deoxyguanosine (8-OHdG) was assessed by a rabbit 8-OHdG ELISA kit (Shanghai Huding Biological Technology Co). Serum antioxidant enzyme superoxide dismutase activity was evaluated by an antioxidant enzyme activities kit (Nanjing Jianchen Bioengineering Institute). Finally, the inflammation marker high-sensitivity C-reactive protein level was also detected using a rabbit high-sensitivity C-reactive protein ELISA kit (Wuhan Huamei Biological Engineering Co,Ltd).
完整版PDF文獻請咨詢在線客服或者電話聯xi我司業務員!
更多公司福利請關注“上海滬鼎”VX公眾號!
相關產品
免責聲明
- 凡本網注明“來源:化工儀器網”的所有作品,均為浙江興旺寶明通網絡有限公司-化工儀器網合法擁有版權或有權使用的作品,未經本網授權不得轉載、摘編或利用其它方式使用上述作品。已經本網授權使用作品的,應在授權范圍內使用,并注明“來源:化工儀器網”。違反上述聲明者,本網將追究其相關法律責任。
- 本網轉載并注明自其他來源(非化工儀器網)的作品,目的在于傳遞更多信息,并不代表本網贊同其觀點和對其真實性負責,不承擔此類作品侵權行為的直接責任及連帶責任。其他媒體、網站或個人從本網轉載時,必須保留本網注明的作品第一來源,并自負版權等法律責任。
- 如涉及作品內容、版權等問題,請在作品發表之日起一周內與本網聯系,否則視為放棄相關權利。